Robert H Getzenberg

1PUBLICATIONS
3CO-AUTHORS
Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 13, 2022
A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent.

Mark C Markowski, Ronald Tutrone, Christopher Pieczonka

Pageof 1